Search research articles
Contact Us
Filters
Showing results (41-50 of 92) with videos related to
Page
of 10
Sort By:
British Medical Journal (Clinical Research Ed.)
|
February 7, 1987
Economic consequences of postinfarction prophylaxis with beta blockers: cost effectiveness of metoprolol
G Olsson, L A Levin, N Rehnqvist
Pharmacoeconomics
|
December 8, 1997
Economic evaluation of desirudin vs heparin in deep vein thrombosis prevention after hip replacement surgery
L A Levin, M Horst, D Bergqvist
Molecular Medicine Today
|
October 26, 1999
'Axogenic' and 'somagenic' neurodegenerative diseases: definitions and therapeutic implications
M Schwartz, E Yoles, L A Levin
Science (New York, N.Y.)
|
June 20, 1980
Contribution to the ellipsoid algorithm
L Blum, P Gács, L A Levin
Lakartidningen
|
August 20, 1986
[Prevention of reinfarction with beta blockaders: socioeconomic effect of metoprolol treatment]
G Olsson, L A Levin, N Rehnqvist
European Heart Journal
|
December 14, 2001
Cost-effectiveness of an invasive strategy in unstable coronary artery disease; results from the FRISC II invasive trial. The Fast Revascularisation during InStability in Coronary artery disease
M Janzon, L A Levin, E Swahn
Journal of Internal Medicine
|
November 1, 1991
Cardiac rehabilitation--a cost analysis
L A Levin, J Perk, B Hedbäck
Investigative Ophthalmology & Visual Science
|
October 1, 1993
Mast cells in human optic nerve
L A Levin, D M Albert, D Johnson
The British Journal of Ophthalmology
|
September 1, 1996
Neural network differentiation of optic neuritis and anterior ischaemic optic neuropathy
L A Levin, J F Rizzo, S Lessell
Journal of Neuroimmunology
|
February 1, 1992
Astrocytes support mast cell viability in vitro
P A Seeldrayers, L A Levin, D Johnson
Page
of 10
Search research articles
Search
Showing results (41-50 of 92) with videos related to
Sort By:
Page
of 10
British Medical Journal (Clinical Research Ed.)
|
February 7, 1987
Economic consequences of postinfarction prophylaxis with beta blockers: cost effectiveness of metoprolol
G Olsson, L A Levin, N Rehnqvist
Pharmacoeconomics
|
December 8, 1997
Economic evaluation of desirudin vs heparin in deep vein thrombosis prevention after hip replacement surgery
L A Levin, M Horst, D Bergqvist
Molecular Medicine Today
|
October 26, 1999
'Axogenic' and 'somagenic' neurodegenerative diseases: definitions and therapeutic implications
M Schwartz, E Yoles, L A Levin
Science (New York, N.Y.)
|
June 20, 1980
Contribution to the ellipsoid algorithm
L Blum, P Gács, L A Levin
Lakartidningen
|
August 20, 1986
[Prevention of reinfarction with beta blockaders: socioeconomic effect of metoprolol treatment]
G Olsson, L A Levin, N Rehnqvist
European Heart Journal
|
December 14, 2001
Cost-effectiveness of an invasive strategy in unstable coronary artery disease; results from the FRISC II invasive trial. The Fast Revascularisation during InStability in Coronary artery disease
M Janzon, L A Levin, E Swahn
Journal of Internal Medicine
|
November 1, 1991
Cardiac rehabilitation--a cost analysis
L A Levin, J Perk, B Hedbäck
Investigative Ophthalmology & Visual Science
|
October 1, 1993
Mast cells in human optic nerve
L A Levin, D M Albert, D Johnson
The British Journal of Ophthalmology
|
September 1, 1996
Neural network differentiation of optic neuritis and anterior ischaemic optic neuropathy
L A Levin, J F Rizzo, S Lessell
Journal of Neuroimmunology
|
February 1, 1992
Astrocytes support mast cell viability in vitro
P A Seeldrayers, L A Levin, D Johnson
Page
of 10